- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04303442
Corona Mortis in Patients Undergoing TEP for Inguinal Hernia
A Prospective Endoscopic Study of the Presence, Type and Size of Corona Mortis in 300 Patients Undergoing Total Extraperitoneal (TEP) Inguinal Hernia Repair Procedures
Study Overview
Status
Intervention / Treatment
Detailed Description
Corona mortis is classically defined as the arterial and/or venous vascular anastomosis between the obturator artery and external iliac artery (most commonly the inferior epigastric artery) that crosses the posterior aspect of the superior ramus of the symphysis pubis. It runs along the posterior aspect of the superior pubic ramus and its laceration can prove life threatening in trauma cases or in scheduled operations.
CMOR is clinically important due to the potential risk of bleeding in pelvic fractures, pelvic and acetabular operations, surgery for urinary incontinence, oncologycal pelvic dissections and laparoscopic hernia repair. It requires special interests from different surgical branches, such as orthopedics, oncologic surgery, urogynecology and general surgery. Vascular anatomy of retropubic area, especially CMOR, should be kept in mind by surgeons performing laparoscopic surgery for hernia repair. In literature, the anatomical data have usually been come from studies performed on cadavers. The aim of this study was to provide in vivo knowledge about the presence, type (venous and/or arterial) and size of CMOR in patients who underwent TEP repair.
300 patients will undergo TEP procedure for unilateral or bilateral inguinal hernias. TEP procedures will be performed with three ports and one or three skin incisions. The presence and type of CMOR will be evaluated, and picture will be made. The size of the CMOR will be defined with ruler inserted true the 10 mm port.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Sofia, Bulgaria
- Sofiamed Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosed primary or recurrence unilateral or bilateral inguinal hernia
- Age between 18 and 90;
Exclusion Criteria:
- Patients who prefer other surgical approach than TEP
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients undergoing TEP
Patients diagnosed with unilateral or bilateral primary and/or recurrence inguinal hernia undergoing Total Extraperitoneal laparoscopic hernia repair.
|
Total extraperitoneal laparoendoscopic hernia repair with one or three skin incisions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of CMOR
Time Frame: Intraoperative
|
Evaluation of presence of Corona mortis in each hemipelvis examined.
For unilateral hernias - one hemipelvis, in bilateral - two hemipelvices.
|
Intraoperative
|
Type CMOR
Time Frame: Intraoperative
|
Evaluation of the type of Corona Mortis - Arterial, Venous or both types, in each hemipelvis
|
Intraoperative
|
Size of CMOR
Time Frame: Intraoperative
|
Evaluation of size of Corona Mortis in mm., measured with ruler.
|
Intraoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 207
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inguinal Hernia
-
Children's Mercy Hospital Kansas CityRecruitingInguinal Hernia | Inguinal Hernia, Indirect | Inguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Hospital General Universitario ElcheCompletedInguinal Hernia | Inguinal Hernia Repair | Open Inguinal Hernia
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalEnrolling by invitationInguinal Hernia | Strangulated Inguinal Hernia | Incarcerated Inguinal HerniaTurkey
-
University Hospital, GhentMedriCompleted
-
Ahmadullah DanishCompletedIncarcerated Inguinal HerniaAfghanistan
-
General Hospital of LarissaUnknown
-
Alexandria UniversityCompletedBilateral Inguinal Hernia
-
Hospital Siberia-SerenaUnknownPrimary Inguinal HerniaSpain
-
Diskapi Teaching and Research HospitalCompleted
Clinical Trials on TEP
-
Sofia Med HospitalActive, not recruiting
-
Stefania La Grutta, MDCompleted
-
VA Office of Research and DevelopmentCompleted
-
Medical Park Gaziantep HospitalMuğla Sıtkı Koçman University; Bahçeşehir UniversityCompletedRecurrence | Hernia, Inguinal | Hernia, Femoral | Inguinal Hernia, Indirect | Inguinal Hernia, Direct | Neuralgia, Atypical | Neuralgia, Ilioinguinal | Neuralgia, Iliohypogastric NerveTurkey
-
Mayo ClinicNational Center for Research Resources (NCRR)Completed
-
University Hospital, LimogesCompleted
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletedType 1 Diabetes MellitusUnited States
-
Erasmus Medical CenterCompletedInguinal HerniaNetherlands
-
Gynaecologisch Oncologisch Centrum ZuidCatharina Ziekenhuis Eindhoven; Amsterdam UMC, location VUmc; The Netherlands... and other collaboratorsRecruiting